R Accelerated Grant supports scientists pursuing original pediatric oncology research to accelerate the discovery of more effective, less toxic therapies and advance better treatments for childhood cancers.
Funder: Alex's Lemonade Stand Foundation
Due Dates (Anticipated): June 2027 (Full application)
Funding Amounts: Up to $800,000 over four years, with a maximum of $200,000 annually in direct costs
Summary: Supports original pediatric oncology research accelerating the discovery of more effective, less toxic childhood cancer therapies.
Key Information: Applicants must be PI or co-PI of their first independent R01 or equivalent award, received within five years.
Alex’s Lemonade Stand Foundation (ALSF) supports scientists pursuing original pediatric oncology projects that advance cures and better treatments for childhood cancers. The four-year R Accelerated Grant funds projects not currently supported by other funding, grounded in a testable hypothesis and strong scientific rationale, with a clear focus on discovering more effective, less toxic therapies.
The program emphasizes significance for childhood cancer, potential clinical impact, and innovation through new concepts, approaches, technologies, or challenges to existing paradigms. Continued commitment to pediatric cancer investigation and institutional support are critical components of a successful application. Recipients are expected to share unique resources generated through the research, and investigators may collaborate with ALSF’s Childhood Cancer Data Lab at no cost.